Table 1.
Patient Characteristics (N = 75).
| Characteristics | N (%) |
|---|---|
| Age (years) | |
| Median (range) | 62 (IQR 55-65) |
| Sex | |
| Male | 65 (86.7) |
| Female | 10 (13.3) |
| ECOG performance status | |
| 0 | 65 (86.7) |
| 1 | 10 (13.3) |
| Tumor stage (AJCC, 7th edition) | |
| IIa | 33 (44.0) |
| IIb | 8 (10.7) |
| IIIa | 23 (30.7) |
| IIIb | 6 (8.0) |
| IIIc | 5 (6.7) |
| T phase | |
| T1 | 4 (5.3) |
| T2 | 8 (10.7) |
| T3 | 60 (80.0) |
| T4a | 3 (4.0) |
| N phase | |
| N0 | 34 (45.3) |
| N1 | 28 (37.3) |
| N2 | 9 (12.0) |
| N3 | 4 (5.3) |
| Tumor location | |
| Upper (<25cm) | 5 (6.7) |
| Middle (25-30cm) | 50 (66.7) |
| Lower (>30cm) | 19 (25.3) |
| Multi-primary | 1 (1.3) |
| Tumor length, cm | |
| Median (range) | 4 (IQR, 3-5) |
| <5 | 45 (60.0) |
| ≥5 | 30 (60.0) |
| Lymphadenectomy | |
| Two-field | 40 (53.3) |
| Three-field | 35 (46.7) |